insights_auto
Why is BOT up ၂၅.၀၀%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၀ A$
arrow_upward
+၂၅.၀၀%(+၀.၀၀၂၀) 1D
နို ၁၇, GMT+၁၁ ၁၆:၁၀:၀၆ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
၀.၀၁ A$
High
၀.၀၁ A$
Low
၀.၀၁ A$
Mkt. cap
၂.၂၁ ကုဋေ
Avg. vol.
၁.၀၉ ကုဋေ
Volume
၁.၀၃ ကုဋေ
52-wk high
၀.၁၅ A$
52-wk low
၀.၀၁ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၂၇ ဋေ
No. of employees
၁၁
Open
၀.၀၁ A$
High
၀.၀၁ A$
Low
၀.၀၁ A$
Mkt. cap
၂.၂၁ ကုဋေ
Avg. vol.
၁.၀၉ ကုဋေ
Volume
၁.၀၃ ကုဋေ
52-wk high
၀.၁၅ A$
52-wk low
၀.၀၁ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၂၇ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
TV News Check
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
marketscreener.com
·
ပြီးခဲ့သည့် ၄၉ မိနစ်
S&P 500 Pullback Extends to Fourth Day Ahead of Nvidia's Earnings
Investing.com
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.64%
Traders Union
·
ပြီးခဲ့သည့် ၅၁ မိနစ်
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd